Dorn Spinal Therapy

Spine Healing Therapy

Get Instant Access

Antunes NL (2000) Acute neurologic complications in children with systemic cancer. J Child Neurol 15:705-716 Antunes NL, Khakoo Y, Matthay KK et al. (2000) Antineuronal antibodies in patients with neuroblastoma and paraneo-plastic opsoclonus-myoclonus. J Pediatr Hematol Oncol 22:315-320

Banerjee S, Marwaha RK, Bajwa RPS (1995) Primary pelvic neuroblastoma with central nervous system metastases. Pediatr Hematol Oncol 12:309-312 Bataller L, Rosenfeld MR, Graus F et al. (2003) Autoantigen diversity in the opsoclonus-myoclonus syndrome. Ann Neurol 53:347-353 Bergman I, Barmada MA, Heller G, Griffin JA, Cheung NKV (1999) Treatment of neoplastic meningeal xenografts by intraventricular administration of an anti-ganglioside monoclonal antibody 3F8. Int J Cancer 82:538-548 Bigner DD, Brown MT, Friedman AH (1998) Iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with recurrent malignant gliomas:phase I trial results. J Clin Oncol 16:2202-2212 Blaes F (2002) Immunotherapeutic approaches to paraneo-plastic neurological disorders. Exp Opin Biol Ther 2:419430

Blatt J, Fitz C, Mirro J (1997) Recognition of central nervous system metastases in children with metastatic primary ex-tracranial neuroblastoma. Pediatr Hematol Oncol 14:233241

Cheung IY, Cheung NKV (2001) Quantitation of marrow disease in neuroblastoma by real-time reverse transcription-PCR. Clin Can Res 7:1698-1705 Cheung NK, Kushner BH, Kramer K (2001) Monoclonal antibody-based therapy of neuroblastoma. Hematol Oncol Clin North Am 15:853-866 Clerico A, Tenore A, Bartolozzi S et al. (1993) Adrenocorti-cotropic hormone-secreting ganglioneuroblastoma associated with opsomyoclonic encephalopathy: a case report with immunohistochemical study. Med Pediatr Oncol 21:690-694

Connolly AM, Pestronk A, Shobhna M et al. (1997) Serum autoantibodies in childhood opsoclonus-myoclonus syndrome: an analysis of antigenic targets in neural tissues. J Pediatr 130:878-884 Conrad E, Olsewski AD, Berger M et al. (1992) Pediatric spine tumors with spinal cord compression. J Pediatr Orthop 12:454-460

Cooper R, Khakoo Y, Matthay KK et al. (2001) Opsoclonus-my-oclonus-ataxia syndrome in neuroblastoma: histopatho-logic features - a report from the children's cancer group. Med Pediatr Oncol 36:623-629 De Bernardi B, Pianca C, Pistamiglio P et al. (2001) Neuroblas-toma with symptomatic spinal cord compression at diagnosis: treatment and results with 76 cases. J Clin Oncol 19: 183-190

DuBois SG, Kalika Y, Lukens JN et al. (1999) Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survival. J Pediatr Hematol Oncol 21:181189

Everson TC, Cole WH (1956) Spontaneous regression of neuroblastoma. In: Everson TC, Cole WH (eds) Spontaneous regression of cancer. Saunders, Philadephia Fisher PG, Wechsler DS, Singer HS (1994) Anti-Hu antibody in a neuroblastoma-associated paraneoplastic syndrome. Pediatr Neurol 10:309-312 Flickinger JC (2001) Radiotherapy and radiosurgical management of brain metastases. Curr Oncol Rep 3:484-489 Fuchs AF, Kaneko CRS, Seudder CA (1985) Brainstem control of saccadic eye movements.Annu Rev Neurosci 8:307-337 Gambini C, Conte M, Bernini G et al. (2003) Neuroblastic tumors associated with opsoclonus-myoclonus syndrome: histological, immunohistochemical and molecular features of 15 Italian cases.Virchows Arch 442:555-562 Gutierrez FA, Oi S, McLone DG (1983) Intraspinal tumors in children: clinical review, surgical results and follow-up in 51 cases. Concepts Pediatr Neurosurg 4:291-405 Hayes FA, Green AA, O'Connor DM (1989) Chemotherapeutic management of epidural neuroblastoma. Med Pediatr Oncol 17:6-8

Hayward K, Jeremy RJ, Jenkins S et al. (2001) Long-term neu-robehavioral outcomes in children with neuroblastoma and opsoclonus-myoclonus-ataxia syndrome: relationship to MRI findings and anti-neuronal antibodies. J Pediatr


Hoover M, Bowman LC, Crawford SE et al. (1999) Long-term outcome of patients with intraspinal neuroblastoma. Med Pediatr Oncol 32:353-359 Yu AL, Uttenreuther-Fischer M, Huang C-S et al. (1998) Phase I trial of a human- mouse chimeric anti-disialoganglioside monoclonal antibody ch 14.18 in patients with refractory neuroblastoma and osteosarcoma. J Clin Oncol 16:21692180

Katzenstein HM, Kent PM, London WB, Cohn SL (2001) Treatment and outcome of 83 children with intraspinal neuroblastoma: the Pediatric Oncology Group experience. J Clin Oncol 19:1047-1055 Kellie JJ, Hayes A, Bowman L et al. (1991) Primary extracranial neuroblastoma with central nervous system metastases: characterization by clinicopathologic findings and neu-roimaging. Cancer 68:1999-2006 Koh PS, Raffensperger JG, Berry S et al. (1994) Long-term outcome in children with opsoclonus-myoclonus and ataxia and coincident neuroblastoma. J Pediatr 125:712-716 Kramer K, Cheung NKV, Humm JL et al. (2000) Targeted ra-dioimmunotherapy for leptomeningeal cancer using 131-I-3F8: patient imaging and dosimetry. Med Ped Oncol 35:716718

Kramer K, Kushner BH, Cheung NKV (2001) Neuroblastoma metastatic to the central nervous system: the Memorial Sloan-Kettering Cancer Center experience and a literature review. Cancer 91:1510-1519

Lassman AB, DeAngelis LM (2003) Brain metastases. Neurol Clin 21:1-15

Lieberman P (2002) On the nature and evolution ofthe neural bases of human language. Am J Phys Anthropol 35 (Suppl): 36-62

LoPiccolo MS, Cheung NK, Cheung IY (2001) GD2 synthase: a new molecular marker for detecting neuroblastoma. Cancer 92:924-931

Martin EF, Beckwith JB (1968) Lymphoid infiltrates in neuro-blastoma: their occurrence and prognostic significance. J Pediatr Surg 3:161-164 Massad M, Haddad F, Slim M et al. (1985) Spinal cord compression in neuroblastoma. Surg Neurol 23:567-572 Matthay KK , Brisse H, Couanet D et al. (2003) Central nervous system metastases in neuroblastoma: radiologic, clinical, and biologic features in 23 patients. Cancer 98:155-165 Mitchell WG, Davalos-Gonzalez Y, Brumm VL et al. (2002) Op-soclonus-ataxia caused by childhood neuroblastoma: developmental and neurologic sequelae. Pediatrics 109:86-98 Papero PH, Pranzatelli MR, Margolis CJ et al. (1995) Neurobe-havioral and psychosocial functioning of children with op-soclonus-myoclonus syndrome. Dev Med Child Neurol


Plantaz D, Hartmann O, Kalifa C, Sainte-Rose C, Lemoine G, Lemerle J (1993) Localized dumbbell neuroblastoma: a study of 25 cases treated between 1982 and 1987 using the same protocol. Med Pediatr Oncol 21:249-253 Plantaz D,Rubie H,Michon J et al.(1996) The treatment of neu-roblastoma with intraspinal extension with chemotherapy followed by surgical removal of residual disease. Cancer


Posner JB (1995) Neurologic complications of cancer. Davis, Philadelphia

Pranzatelli MR (1992) The neurobiology of opsoclonus-my-

oclonus. Clin Neuropharmacol 15:186-228 Pranzatelli MR (1994) On the molecular mechanism of adrenocorticotropic hormone: neurotransmitters and receptors. Exp Neurol 125:142-161 Pranzatelli MR (1996) The immunopharmacology of the opso-clonus-myoclonus syndrome. Clin Neuropharmacol 19:1-47 Pranzatelli MR (2000) Friendly fire. Discover April:35-36 Pranzatelli MR, Huang Y, Tate E et al. (1998a) Effect of high dose corticotropin on cerebrospinal fluid monoaminergic neurotransmitters or metabolites in corticotropin-responsive pediatric opsoclonus-myoclonus. Mov Disord 13:522-528 Pranzatelli MR, Hanin I, Tate E et al. (1998b) Cerebrospinal fluid free choline in movement disorders of pediatric onset. Eur J Pediatr Neurol 1:33-39 Pranzatelli MR, Tate ED, Kinsbourne M et al. (2002a) Forty-one year follow-up of childhood-onset opsoclonus-myoclonus: cerebellar atrophy, multiphasic relapses, response to IVIG. Mov Disord 17:1387-1390 Pranzatelli MR, Tate ED, Wheeler A et al. (2002b) Screening for autoantibodies in children with opsoclonus-myo-clonus-ataxia. Pediatr Neurol 27:384-387

Punt J, Pritchard J, Pincott JR et al. (1980) Neuroblastoma: a review of 21 cases presenting with intra-spinal extension. Cancer 45:3095-3101 Reddy AT, Witek K (2003) Neurologic complications of chemotherapy for children with cancer. Curr Neurol Neu-rosci Rep 3:137-142 Rohrlich P, Hartmann O, Couanet D et al. (1989) Localisations neuro-meninges metastaques secondaires dans les neuro-blastomes de l'enfant. Arch Fr Pediatric 46:5-10 Rudnick E, Khakoo Y, Antunes N, Seeger RC, Brodeur GM, Shimada H, Gerbing RB, Stram DO, Matthay KK (2001a) Opsoclonus-myoclonus-ataxia syndrome in neuroblas-toma: clinical outcome and anti-neuronal antibodies: a Children's Cancer Group study. Med Pediatr Oncol 36: 612-622

Rudnick E, Khakoo Y, Antunes NL et al. (2001b) Opso-clonus-myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineuronal antibodies - a report from the Children's Cancer Group Study. Med Pediatr Oncol 36:612-622

Russo C, Cohn SL, Petruzzi MJ, de Alarcon PA (1997) Long-term neurologic outcome in children with opsoclonus-myo-clonus associated with neuroblastoma: a report from the Pediatric Oncology Group. Med Pediatr Oncol 28:284-288 Sandberg DI, Bilsky M, Kushner BH et al. (2003) Treatment of spinal involvement in neuroblastoma patients. Pediatr Neurosurg 39:291-298 Shaw PJ (1992) Neuroblastoma with intracranial involvement:

an ENSG Study. Med Pediatr Oncol 20:149-155 Stubbs EB Jr, Lawlor MW, Richards MP et al. (2003) Anti-neurofilament antibodies in neuropathy with monoclonal gam-mopathy of undetermined significance produce experimental motor nerve conduction block. Acta Neuropathol (Berl) 105:109-116 Tasdemiroglu E, Patchell RA (1997) Neurologic examinations of the primary pediatric extracranial neuroblastomas.Neu-rol Res 19:45-50 Tasdemiroglu E, Ayan I, Kebudi R (1998) Extracranial neuro-blastomas and neurologic complications. Child Nerv Syst


Tate ED, Pranzatelli MR, Huang Y et al. (1994) An innovative approach to the problem of sedating children with opso-clonus-myoclonus syndrome: effects of myoclonus and CSF monoamine metabolites. Ann Neurol 36:543-544 Vines EF, Le Pechoux C,Arriagada R (2003) Prophylactic cranial irradiation in small cell lung cancer. Semin Oncol 30:38-46 Weinberg JS, Lang FF, Sawaya R (2001) Surgical management of brain metastases. Curr Oncol Rep 3:476-483 Wilberg JE, Muceniece R, Mandrika I et al. (2000) New aspects on the melanocortins and their receptors. Pharmacol Res


Yu AL, Uttenreuther-Fischer M, Huang C-S et al. (1998) Phase I trial of a human- mouse chimeric anti-disialoganglioside monoclonal antibody ch 14.18 in patients with refractory neuroblastoma and osteosarcoma. J Clin Oncol 16:2169-2180

Was this article helpful?

0 0
10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook

Post a comment